Acting ARENA CEO Ian Kay said the funding would enable NSW company Dyesol to create a roadmap setting out the steps needed to take its perovskite solar cell technology from the lab to a commercially available product.
Perovskite cells have been demonstrated at laboratory scale but have never before been mass produced. Dyesol will map out the techniques and requirements for working towards scalable manufacturing of high-quality, uniform perovskite cells that achieve efficiency, durability and stability targets, Mr Kay said.
Most current generation solar photovoltaic (PV) panels on the market today are made with silicon, but there is growing interest in developing third generation solar technologies such as cells constructed from perovskite.
Perovskite is abundant and cheaper than silicon and there are signs it may be more adaptable than conventional silicon, providing enhanced performance in low light conditions and being better suited for integration into external building components, such as windows and facades.
Ultimately, we hope to see perovskite solar cells deliver a significant breakthrough in cost reduction in the manufacture of solar PV technology, in line with ARENAs goal of reducing the cost of renewable energy and advancing innovative technologies.
Dyesol is initially aiming for a delivery cost benchmark of US 10 cents per kWh, putting perovskite solar PV cells on par with current benchmarks achieved by silicon solar PV. This would be a considerable achievement given silicon PVs maturity as a technology, and provides further scope for reduction in the cost of energy as manufacturing volumes grow.
Perovskite was named by Science magazine as one of the renewable energy breakthroughs of 2013. In recent years, there have been significant advancements in the technology, with Dyesol working globally with companies and researchers to develop an international leadership position in the field.
Dyesol Chief Technical Officer Dr Damion Milliken said ARENAs support would help the company develop international market leadership by bedding down critical manufacturing input materials and techniques necessary for commercialization of a perovskite solar cell product.
This project is about capacity building in the Australian perovskite solar cell space, where world-leading expertise exists on both the academic and industrial scenes, Dr Milliken said.
ARENAs funding will be invaluable in accelerating commercialization of this transformational solar PV technology and ensuring Australia is at the forefront of this development.